Healthcare Services

Clinical Trial Imaging Market Expected to Record Steady Growth and Approach $2.36 Billion by 2030

March 31, 2026April 6, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Will Be The Estimated Market Valuation Of The Clinical Trial Imaging Market By The End Of 2030?

The clinical trial imaging market has experienced robust growth in recent years. Projections indicate it will expand from $1.58 billion in 2025 to reach $1.72 billion by 2026, exhibiting a compound annual growth rate (CAGR) of 9.3%. The expansion observed historically can be ascribed to several factors, including the increasing intricacy of clinical trial protocols, a growing utilization of imaging endpoints in oncology trials, the global expansion of clinical trials, a heightened regulatory emphasis on imaging accuracy, and the availability of advanced imaging modalities.

The clinical trial imaging market is projected to experience substantial expansion in the coming years. This market is set to reach $2.36 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.2%. Factors contributing to this anticipated growth include the increasing uptake of decentralized clinical trials, rising investments in AI-powered imaging platforms, a growing need for real-time imaging analytics, the expansion of precision medicine trials, and enhanced integration of imaging with clinical data platforms. Key trends during this period are expected to encompass the growing adoption of AI-assisted image analysis, an increasing utilization of multi-modality imaging in trials, a rising demand for centralized image management services, the expansion of remote imaging review functionalities, and a heightened emphasis on imaging standardization and quality control.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15765&type=smp

What Drivers Are Shaping The Future Growth Of The Clinical Trial Imaging Market?

The future expansion of the clinical trial imaging market is anticipated to be driven by the rising incidence of chronic diseases. These are persistent health conditions necessitating continuous medical care, often impacting daily routines or overall well-being. Environmental factors like air pollution, chemical exposure, and toxins, alongside lifestyle shifts and genetic predispositions, contribute to the growing occurrence of chronic illnesses. Through effective imaging, clinical trial imaging offers thorough monitoring, aiding patients in comprehending their ailments and treatment effects, thereby boosting compliance and contentment. As an illustration, data from January 2023, sourced from the National Center for Biotechnology Information (NCBI), a US-based National Library of Medicine, indicates a significant projection: by the year 2050, the population of individuals aged 50 years and above experiencing at least one chronic illness is expected to increase by 99.5%, escalating from 71.522 million in 2020 to 142.66 million. Consequently, the expanding occurrence of chronic diseases serves as a key impetus for the clinical trial imaging market.

Which Segment Classifications Shape The Clinical Trial Imaging Market?

The clinical trial imaging market covered in this report is segmented –

1) By Product And Services: Services, Software

2) By Modality: Computed Tomography, Magnetic Resonance Imaging, Echocardiography, Nuclear Medicine, Positron Emission Tomography, X-Ray, Ultrasound, Optical Coherence Tomography, Other Modalities

3) By Application: Oncology, Neurology, Cardiology, Endocrinology, Dermatology, Hematology, Other Applications

4) By End User: Contract Research Organizations, Pharmaceutical And Biotechnology Companies, Medical Device Manufacturers, Academic And Government Research Institutes, Other End-Users

Subsegments:

1) By Services: Imaging Services For Diagnostics, Image Acquisition Services, Image Analysis Services, Image Management And Archiving Services

2) By Software: Imaging Software For Analysis, Image Processing Software, Radiology Information Systems (RIS), Picture Archiving And Communication Systems (PACS)

How Are Trends Transforming The Clinical Trial Imaging Market Landscape?

Leading firms within the clinical trial imaging market are creating cloud-powered image utilities to offer enhanced solutions and boost the effectiveness of clinical trials. These cloud-based imaging tools represent software applications and platforms leveraging cloud computing for the storage, management, and analysis of medical imagery. As an example, in March 2023, Clarion, a US-based producer of sophisticated power distribution systems, introduced an innovative cloud-based image viewer. This novel instrument facilitates real-time, on-demand viewing and editing of high-resolution images, delivering read-quality image access almost instantly and removing previously necessary manual processes. It optimizes the image viewing workflow by doing away with manual stages, ensuring image access is simple, secure, and adheres to data privacy regulations. The utility provides complete resolution viewing and manipulation functionalities, enabling users to derive significant insights concerning their trial subjects.

Which Companies Are Expanding Their Footprint In The Clinical Trial Imaging Market?

Major companies operating in the clinical trial imaging market are Koninklijke Philips N.V., Labcorp Drug Development, ICON Plc, PPD Inc., Syneos Health, Charles River Laboratories, Parexel International Corporation, Clario, Medpace Inc., Medidata Solutions Inc., Biotelemetry Inc., ProScan Imaging LLC, Invicro LLC, Perspectum, Intrinsic Imaging LLC, Datatrak Inc., IXICO Plc, Calyx Inc., Resonance Health Ltd., Anagram-ESIC SL

Read the full clinical trial imaging market report here:

https://www.thebusinessresearchcompany.com/report/clinical-trial-imaging-global-market-report

Which Geographic Regions Are Influencing Demand In The Clinical Trial Imaging Market?

North America was the largest region in the clinical trial imaging market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the clinical trial imaging market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Clinical Trial Imaging Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=15765&type=smp

Browse Through More Reports Similar to the Global Clinical Trial Imaging Market 2026, By The Business Research Company

Clinical Trial Supplies Global Market Report

https://www.thebusinessresearchcompany.com/report/clinical-trial-supplies-global-market-report

Clinical Trial Supply And Logistics Global Market Report

https://www.thebusinessresearchcompany.com/report/clinical-trial-supply-and-logistics-global-market-report

Clinical Trial Management Systems Global Market Report

https://www.thebusinessresearchcompany.com/report/clinical-trial-management-systems-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795